Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population.

2015

https://researcherprofiles.org/profile/1196920

26547049

van Kempen BJ, Ferket BS, Steyerberg EW, Max W, Myriam Hunink MG, Fleischmann KE